相关实验视频
Updated: Jul 14, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
肌缩性侧面硬化症 (AMLS) 是一种疾病
1Motor Neurone Disease Care and Research Centre, Royal Preston Hospital, Fulwood, Preston PR2 9HT, UK.
Lancet (London, England)
|June 19, 2007
概括
肌缩侧面硬化症 (ALS) 或运动神经元疾病是一种复杂的神经系统疾病. 本综述涵盖了ALS自然史,原因,治疗,症状管理以及未来的研究方向,如干细胞治疗.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
背景情况:
- 肌缩性侧面硬化症 (ALS),也称为运动神经元疾病,在理解其发病过程中提出了复杂的挑战.
- 这种状况影响着全球的个体,需要对其多方面的方面进行全面的审查.
研究的目的:
- 提供关于肌缩侧面硬化症 (ALS) 的全面概述.
- 讨论关于ALS自然史,临床特征,诊断,遗传学和流行病学的当前知识.
- 探索潜在的原因,治疗方法,症状管理,以及未来的ALS研究途径.
主要方法:
- 关于肌缩侧面硬化症 (ALS) 的文献综述.
- 综合有关ALS自然史,临床表现,诊断标准和流行病学的信息.
- 讨论病因假设,治疗策略和疾病管理.
主要成果:
- ALS的特点是不确定的发病,其中包括兴奋毒性和氧化应激等假设.
- 管理策略包括症状控制 (消化不良,消炎症,呼吸困难,疼痛,心理障碍) 和息护理.
- 未来的前景包括疾病标志物,干细胞和ALS的基因治疗.
结论:
- 有效管理ALS需要解决患者和家人的身体,心理和精神需求.
- 对疾病标志物和干细胞和基因疗法等新型疗法的持续研究对ALS有希望.
- 多学科的方法对于优化护理和阿米奥托菲斯侧面硬化症 (ALS) 的结果至关重要.
相关概念视频
Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

